These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 8887065)

  • 1. Use of regression analysis and flow cytometry for determining levels of mixed semiallogeneic immune chimerism.
    Ramsamooj R; Patel MP; Llull R; Levin S; Black KS; Hewitt CW
    J Invest Surg; 1996; 9(4):273-81. PubMed ID: 8887065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined treatment with regulatory T cells and vascularized bone marrow transplantation creates mixed chimerism and induces donor-specific tolerance to vascularized composite allografts without cytoreductive conditioning.
    Lin JY; Tsai FC; Wallace CG; Huang WC; Wei FC; Liao SK
    J Surg Res; 2012 Dec; 178(2):974-81. PubMed ID: 22819314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular mechanisms of alloimmune non-responsiveness in tolerant mixed lymphocyte chimeras induced by vascularized bone marrow transplants.
    Llull R; Ramsamooj R; Black KS; Hewitt CW
    Transpl Int; 1994; 7 Suppl 1():S453-6. PubMed ID: 11271279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of stable mixed T cell chimerism and transplantation tolerance without immune modulation in recipients of vascularized bone marrow allografts.
    Hewitt CW; Ramsamooj R; Patel MP; Yazdi B; Achauer BM; Black KS
    Transplantation; 1990 Nov; 50(5):766-72. PubMed ID: 2238052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of thymus in operational tolerance induction in limb allograft transplant model.
    Siemionow M; Izycki D; Ozer K; Ozmen S; Klimczak A
    Transplantation; 2006 Jun; 81(11):1568-76. PubMed ID: 16770246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesenchymal stem cells enhance the induction of mixed chimerism and tolerance to rat hind-limb allografts after bone marrow transplantation.
    Pan H; Zhao K; Wang L; Zheng Y; Zhang G; Mai H; Han Y; Yang L; Guo S
    J Surg Res; 2010 May; 160(2):315-24. PubMed ID: 19524257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascularized bone marrow transplantation (VBMT): induction of stable mixed T-cell chimerism and transplantation tolerance in unmodified recipients.
    Yazdi B; Patel MP; Ramsamooj R; Llull R; Achauer BM; Black KS; Hewitt CW
    Transplant Proc; 1991 Feb; 23(1 Pt 1):739-40. PubMed ID: 1990672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and maintenance of donor-specific chimerism in semi-allogenic and fully major histocompatibility complex mismatched facial allograft transplants.
    Siemionow M; Demir Y; Mukherjee A; Klimczak A
    Transplantation; 2005 Mar; 79(5):558-67. PubMed ID: 15753845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of regression analysis and the complement-dependent cytotoxicity typing assay for predicting lymphoid chimerism.
    Henson LE; Hewitt CW; Black KS
    J Immunol Methods; 1988 Nov; 114(1-2):139-44. PubMed ID: 3053906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chimerism induction in vascularized bone marrow transplants augmented with bone marrow cells.
    Arslan E; Klimczak A; Siemionow M
    Microsurgery; 2007; 27(3):190-9. PubMed ID: 17326192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chimerism and tolerance in rat recipients of intestinal allografts from ALS-treated donors with and without adjunct naïve-donor-strain bone-marrow cells.
    Nakao A; Nalesnik MA; Ishikawa T; Azhipa O; Demetris AJ; Murase N
    Transplantation; 2003 May; 75(9):1575-81. PubMed ID: 12792518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mixed allogeneic chimerism as a reliable model for composite tissue allograft tolerance induction across major and minor histocompatibility barriers.
    Foster RD; Ascher NL; McCalmont TH; Neipp M; Anthony JP; Mathes SJ
    Transplantation; 2001 Sep; 72(5):791-7. PubMed ID: 11571439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New composite tissue allograft model of vascularized bone marrow transplant: the iliac osteomyocutaneous flap.
    Nasir S; Klimczak A; Sonmez E; Bozkurt M; Gibson S; Siemionow M
    Transpl Int; 2010 Jan; 23(1):90-100. PubMed ID: 19686290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mixed allogeneic chimerism in the rat. Donor-specific transplantation tolerance without chronic rejection for primarily vascularized cardiac allografts.
    Colson YL; Zadach K; Nalesnik M; Ildstad ST
    Transplantation; 1995 Nov; 60(9):971-80. PubMed ID: 7491703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of alloimmune tolerance associated with mixed chimerism induced by vascularized bone marrow transplants.
    Ramsamooj R; Llull R; Patel MP; Beko KR; Black KS; Hewitt CW
    Cell Transplant; 2002; 11(7):683-93. PubMed ID: 12518895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of donor-specific transplantation tolerance to skin and cardiac allografts using mixed chimerism in (A + B-->A) in rats.
    Markus PM; Selvaggi G; Cai X; Fung JJ; Starzl TE
    Cell Transplant; 1993; 2(4):345-53. PubMed ID: 8162277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel rat full-thickness hemi-abdominal wall/hindlimb osteomyocutaneous combined flap: influence of allograft mass and vascularized bone marrow content on vascularized composite allograft survival.
    Ramirez AE; Cheng HY; Lao WW; Wang YL; Wen CJ; Wallace CG; Lin CF; Shih LY; Chuang SH; Wei FC
    Transpl Int; 2014 Sep; 27(9):977-86. PubMed ID: 24861714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term survival of composite hemiface/mandible/tongue allografts correlates with multilineage chimerism development in the lymphoid and myeloid compartments of recipients.
    Kulahci Y; Klimczak A; Madajka M; Altuntas S; Siemionow M
    Transplantation; 2010 Oct; 90(8):843-52. PubMed ID: 20697324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Composite tissue (limb) allografts in rats. III. Development of donor-host lymphoid chimeras in long-term survivors.
    Hewitt CW; Black KS; Dowdy SF; Gonzalez GA; Achauer BM; Martin DC; Furnas DW; Howard EB
    Transplantation; 1986 Jan; 41(1):39-43. PubMed ID: 2867627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of tolerance to hind limb allografts in rats receiving cyclosporine A and antilymphocyte serum: effect of duration of the treatment.
    Ozer K; Oke R; Gurunluoglu R; Zielinski M; Izycki D; Prajapati R; Siemionow M
    Transplantation; 2003 Jan; 75(1):31-6. PubMed ID: 12544867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.